Company Filing History:
Years Active: 2004-2006
Title: Kenneth Curry: Innovator in Neuropharmaceuticals
Introduction
Kenneth Curry is a notable inventor based in Vancouver, Canada. He has made significant contributions to the field of neuropharmaceuticals, particularly through his innovative work on compounds that target the metabotropic glutamate receptor system. With a total of 3 patents to his name, Curry's inventions hold promise for treating various central nervous system disorders.
Latest Patents
Curry's latest patents include the development of 2-aminoindane analogs. This invention relates to therapeutically active compounds that act as modulators of metabotropic glutamate receptors. The compounds are useful in treating diseases of the central nervous system related to this receptor system. Another significant patent involves cubane derivatives, which are also designed as metabotropic glutamate receptor agonists or antagonists. This invention includes a method for preparing these compounds and pharmaceutical compositions that incorporate them.
Career Highlights
Kenneth Curry is currently associated with Prescient Neuropharma Inc., where he continues to advance his research and development efforts. His work focuses on creating innovative solutions for neurological conditions, showcasing his commitment to improving patient outcomes through scientific discovery.
Collaborations
Curry collaborates with fellow researcher Hassan Pajouhesh, working together to explore new therapeutic avenues in neuropharmacology. Their partnership exemplifies the collaborative spirit that drives innovation in the field.
Conclusion
Kenneth Curry's contributions to neuropharmaceuticals through his patents and collaborations highlight his role as a key innovator in the industry. His work continues to pave the way for advancements in treating central nervous system disorders.